oral glp-1 agonists new glp 1 agonist In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron Removing the needle: the unmet
Description
J Cell Physiol 1997
( Epub 2021/11/25 )
The findings have not been replicated in robust controlled studies
Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research
van Dam, E
